XML 119 R102.htm IDEA: XBRL DOCUMENT v3.24.2
Note 19 - Stockholders' Equity (Details Textual)
 12 Months Ended
Oct. 02, 2023
USD ($)
Sep. 12, 2023
USD ($)
shares
Jun. 22, 2023
Jul. 12, 2022
USD ($)
May 31, 2024
USD ($)
shares
May 31, 2023
USD ($)
shares
May 31, 2022
USD ($)
May 31, 2021
USD ($)
Apr. 30, 2021
shares
Common Stock, Shares Authorized (in shares)         1,198,000,000 980,000,000      
Preferred Stock, Shares Authorized (in shares)         10,000,000 10,000,000      
Common Stock, Shares, Issued (in shares)         831,925,373 656,655,455      
Preferred Stock, Shares Issued (in shares)         0 0      
Stock Issued During Period, Value, Settlement of Financing Liability | $         $ 21,487,000 $ 12,467,000 $ (7,484,000)    
Repayments of Convertible Debt | $         $ 107,330,000 187,394,000 88,026,000    
Stock Issued During Period, Value, Equity Financing | $           129,593,000 262,509,000    
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture (in shares)         4,351,237        
Share-Based Payment Arrangement, Expense | $         $ 31,769,000 $ 39,595,000 $ 35,994,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)         0        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)         244,193 371,182      
Common Stock, Shares, Outstanding (in shares)         831,925,373 656,655,455      
Preferred Stock, Shares Outstanding (in shares)         0 0      
HEXO [Member]                  
Business Combination, Common Share Exchange Ratio     0.4352            
Tilray Two Thousand And Eighteen Equity Incentive Plan And Original Plan [Member]                  
Stock Issued During Period, Value, Issued for Services | $         $ 500,000        
Stock Granted, Fair Value Share Based Compensation | $         $ 1,000,000        
Common Stock, Capital Shares Reserved for Future Issuance (in shares)                 9,806,851
Common Stock Capital Shares Reserved For Future Issuance, Annual Automatic Increase Percentage         4.00%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         0 0      
Predecessor Plan [Member] | Aphria [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         0 0      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)         434,212        
Predecessor Plan [Member] | HEXO [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)         1,144,218        
Business Combination, Common Share Exchange Ratio         0.4352        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Converted Upon Acquisition, Number (in shares)         1,267,793        
Share-Based Payment Arrangement, Plan Modification, Incremental Cost | $               $ 0  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number (in shares)         1,120,768        
Time-based Restricted Stock Units [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)         13,680,556 6,004,995      
Performance-based Restricted Stock Units [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)         7,566,146 2,634,744      
Restricted Stock Units (RSUs) [Member] | Tilray Two Thousand And Eighteen Equity Incentive Plan And Original Plan [Member] | Minimum [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)         3 years        
Restricted Stock Units (RSUs) [Member] | Tilray Two Thousand And Eighteen Equity Incentive Plan And Original Plan [Member] | Maximum [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)         4 years        
Stock Appreciation Rights (SARs) [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)         0        
Stock Appreciation Rights (SARs) [Member] | Tilray Two Thousand And Eighteen Equity Incentive Plan And Original Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)         0        
Stock Appreciation Rights (SARs) [Member] | Tilray Two Thousand And Eighteen Equity Incentive Plan And Original Plan [Member] | Maximum [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)         10 years        
At-the-Market Program [Member]                  
Stock Issued During Period, Shares, Equity Financing (in shares)         5,327,843        
Stock Issued During Period, Value, Equity Financing | $         $ 9,944,000        
Payments of Stock Issuance Costs | $         1,325,000        
Net Proceeds from Issuance of Common Stock | $         $ 8,619,000        
HT Investments MA LLC Note [Member]                  
Stock Issued During Period, Shares, For Derivative Settlement (Downside Protection) (in shares)         17,148,541        
HT Investments MA LLC Note [Member] | Derivative Settlement [Member]                  
Stock Issued During Period, Shares, For Derivative Settlement (Downside Protection) (in shares)         1,032,616        
HTI Convertible Note Payable [Member]                  
Repayments of Convertible Debt | $       $ 50,000,000          
Tilray Brands Inc MediPharm / HEXO Litigation Settlement [Member]                  
Stock Issued During Period, Shares, Legal Settlement (in shares)         1,573,152        
TLRY 23 [Member]                  
Repayments of Convertible Debt | $ $ 107,331,000 $ 610,000              
Stock Issued During Period, Shares, For The Repayment of Convertible Debt (in shares)   7,000,000     7,000,000        
Convertible Debt Instrument, Repurchase Amount | $         $ 20,000,000        
APHA 24 [Member]                  
Stock Issued During Period, Shares, For The Repayment of Convertible Debt (in shares)         73,484,147        
Convertible Debt Instrument, Repurchase Amount | $         $ 349,670,000        
Aphria Diamond [Member]                  
Stock Issued During Period, Shares, Settlement of Dividend Payable (in shares)         24,780,994        
HEXO [Member]                  
Stock Issued During Period, Shares, Purchase of Assets (in shares)         39,705,962        
Stock Issued During Period, Shares, Settlement of Financing Liability (in shares)         865,426        
Stock Issued During Period, Value, Settlement of Financing Liability | $         $ 1,500,000